Published in

Springer Nature [academic journals on nature.com], British Journal of Cancer, 5(118), p. 679-697, 2018

DOI: 10.1038/bjc.2017.473

Links

Tools

Export citation

Search in Google Scholar

Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO